Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adeno-associated virus gene therapy for 21-hydroxylase deficiency

Adeno-associated virus gene therapy for 21-hydroxylase deficiency

US Patent 12195767 · Granted Jan 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV-mediated gene therapy for maple syrup urine disease (MSUD)2025
Minigene therapy2025
Modified AAV constructs and uses thereof2025
Viral vector production2025
Gene therapeutics for treating bone disorders2025
Modified AAV constructs and uses thereof2024
Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 2024
Compositions and methods for transient delivery of nucleases2024
Recombinant adeno-associated viruses for delivering gene editing molecules to em2024
Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization2023
AAV's and uses thereof2023
Isolation of novel AAV's and uses thereof2023